Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
8.09
0.00 (0.00%)
Sep 3, 2025, 8:44 AM - Market open

Addex Therapeutics Revenue

Addex Therapeutics had revenue of 71.06K CHF in the quarter ending March 31, 2025, a decrease of -69.75%. This brings the company's revenue in the last twelve months to 246.19K, down -81.76% year-over-year. In the year 2024, Addex Therapeutics had annual revenue of 410.04K, down -74.64%.

Revenue (ttm)
246.19K CHF
Revenue Growth
-81.76%
P/S Ratio
24.63
Revenue / Employee
123,094 CHF
Employees
2
Market Cap
6.86M USD

Revenue Chart

* This company reports financials in CHF.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024410.04K-1.21M-74.64%
Dec 31, 20231.62M172.23K11.92%
Dec 31, 20221.44M-1.71M-54.18%
Dec 31, 20213.15M-725.84K-18.71%
Dec 31, 20203.88M1.05M36.89%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.